News Hikma will pay $150m in US opioid settlement Indian drugmaker Hikma has agreed in principle to a $150 million settlement to resolve lawsuits claiming that it contributed to the opioid crisis in the US, which could al
News Kara Dugan joins Razorfish Health as president Publicis Health has named Kara Dugan as president of Razorfish Health, effective immediately.
News AZ boasts phase 3 win for self-administered gMG drug Alexion has announced high-level positive results from a phase 3 trial of gefurulimab, a once-weekly self-administered treatment for gMG.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face